Our recent studies demonstrated that ERBB1 expression was upregulated in MM cells, and higher levels of ERBB1 were associated with poor treatment outcomes and survival in newly diagnosed MM [22]. The gene discussed is EGFR; the disease is Miyoshi myopathy.